Lieven Annemans

Lieven Annemans is Senior Full Professor of Economics of Health and Wellbeing at the Department of Public Health within the Faculty of medicine and health sciences at Ghent University, Belgium.

He is also guest professor at the Vienna School of clinical research and at the EMS management school in Brussels.

He is Past-President of ISPOR (the International Society of PharmacoEconomics and Outcomes Research) and was during 8 years chairman of the Flemish health council (Flanders, Belgium). During the COVID pandemic he was 4 years chairman of the Flemish committee for societal revival, advising the Flemish Government.

He conducts health economics research since 30 years, specialising in cost-effectiveness analysis of public health interventions and health technology assessment (HTA). He is (co)-author of >320 scientific papers in peer-reviewed journals, provided >900 international and national lectures, and published several books, among which ‘Health economics for non-economists’ (Pelckmans Pro, 2018).

Domains of expertise

  • Health Economics
  • Health Technology Assessment
  • Artificial Intelligence
  • Healthcare Services Research
  • Economics of Wellbeing

Selected projects & research platforms

Selected publications

  • Annemans, Lieven, et al. “‘Highest Risk-Highest Benefit’ Strategy : A Pragmatic, Cost-Effective Approach to Targeting Use of PCSK9 Inhibitor Therapies.” EUROPEAN HEART JOURNAL, vol. 39, no. 27, 2018, pp. 2546–50, doi:10.1093/eurheartj/ehx710.
  • Annemans L. A proposal for value informed, affordable ("via") prices for innovative medicines. J Med Econ. 2019 Nov;22(11):1235-1239. doi: 10.1080/13696998.2019.1632203. Epub 2019 Jul 8. PMID: 31199174.
  • Tack P, Victor J, Gemmel P, Annemans L. 3D-printing techniques in a medical setting: a systematic literature review. Biomed Eng Online. 2016 Oct 21;15(1):115.

Work details